Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model

Critical Care

Volumn 14, Issue 4, 2010, Pages

  Lange, Matthias ^a,b   Connelly, Rhykka ^a   Traber, Daniel L ^a   Hamahata, Atsumori ^a,c   Nakano, Yoshimitsu ^a   Esechie, Aimalohi ^a   Jonkam, Collette ^a   von Borzyskowski, Sanna ^a   Traber, Lillian D ^a   Schmalstieg, Frank C ^a   Herndon, David N ^d   Enkhbaatar, Perenlei ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; NITRITE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); 3-NITROTYROSINE; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; NITRATE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FLUID RESUSCITATION; HEMODYNAMICS; LUNG PARENCHYMA; NITRATION; NITROSATIVE STRESS; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PULMONARY SHUNT; SHAM PROCEDURE; SHEEP; TIME PERCEPTION; ACUTE LUNG INJURY; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; ENZYMOLOGY; LUNG; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; TIME;

ACUTE LUNG INJURY; ANIMALS; DISEASE MODELS, ANIMAL; INTERLEUKIN-8; LUNG; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; POLY ADENOSINE DIPHOSPHATE RIBOSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; SHEEP; TIME FACTORS; TYROSINE;

EID: 77954156068     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9097     Document Type: Article

References (33)

1. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 168:165-172. 10.1164/rccm.2201087, 12851245.
2. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993, 94:281-288. 10.1016/0002-9343(93)90060-3, 8452152.
3. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 1989, 129:1258-1267.
4. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353. 10.1097/01.CCM.0000194725.48928.3A, 16424713.
5. Lange M, Connelly R, Traber DL, Hamahata A, Cox RA, Nakano Y, Bansal K, Esechie A, von Borzyskowski S, Jonkam C, Traber LD, Hawkins HK, Herndon DN, Enkhbaatar P. Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. Crit Care Med 2009, 37:223-229. 10.1097/CCM.0b013e3181926104, 19050630.
6. Maybauer DM, Maybauer MO, Szabo C, Westphal M, Traber LD, Enkhbaatar P, Murthy KG, Nakano Y, Salzman AL, Herndon DN, Traber DL. Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity. Biochem Biophys Res Commun 2008, 377:786-791. 10.1016/j.bbrc.2008.10.066, 2628331, 18951875.
7. Murakami K, Enkhbaatar P, Shimoda K, Cox RA, Burke AS, Hawkins HK, Traber LD, Schmalstieg FC, Salzman AL, Mabley JG, Komjati K, Pacher P, Zsengeller Z, Szabo C, Traber DL. Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis. Shock 2004, 21:126-133. 10.1097/01.shk.0000108397.56565.4a, 14752285.
8. Murakami K, Bjertnaes LJ, Schmalstieg FC, McGuire R, Cox RA, Hawkins HK, Herndon DN, Traber LD, Traber DL. A novel animal model of sepsis after acute lung injury in sheep. Crit Care Med 2002, 30:2083-2090. 10.1097/00003246-200209000-00022, 12352045.
9. Lange M, Hamahata A, Enkhbaatar P, Esechie A, Connelly R, Nakano Y, Jonkam C, Cox RA, Traber LD, Herndon DN, Traber DL. Assessment of vascular permeability in an ovine model of acute lung injury and pneumonia-induced Pseudomonas aeruginosa sepsis. Crit Care Med 2008, 36:1284-1289. 10.1097/CCM.0b013e318169ef74, 18379256.
10. Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, Traber L, Phillips G, Parkinson J, Salsbury JR, Biondo N, Schmalstieg F, Burke A, Cox R, Hawkins H, Herndon D, Traber D. Inducible nitric oxide synthase dimerization inhibitor prevents cardiovascular and renal morbidity in sheep with combined burn and smoke inhalation injury. Am J Physiol Heart Circ Physiol 2003, 285:H2430-2436.
11. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996, 6:79-88. 10.1097/00024382-199608000-00001, 8856840.
12. Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007, 6:662-680. 10.1038/nrd2222, 17667957.
13. Szabo C. DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic Biol Med 1996, 21:855-869. 10.1016/0891-5849(96)00170-0, 8902531.
14. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994, 263:687-689. 10.1126/science.8080500, 8080500.
15. Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997, 100:723-735. 10.1172/JCI119585, 508242, 9239421.
16. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004, 32:21-30. 10.1097/01.CCM.0000105581.01815.C6, 14707556.
17. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 1997, 29:159-166.
18. Titheradge MA. Nitric oxide in septic shock. Biochim Biophys Acta 1999, 1411:437-455. 10.1016/S0005-2728(99)00031-6, 10320674.
19. Enkhbaatar P, Lange M, Nakano Y, Hamahata A, Jonkam C, Wang J, Jaroch S, Traber L, Herndon D, Traber D. Role of neuronal nitric oxide synthase in ovine sepsis model. Shock 2009, 32:253-257. 10.1097/SHK.0b013e318193e2ba, 19008779.
20. Gocan NC, Scott JA, Tyml K. Nitric oxide produced via neuronal NOS may impair vasodilatation in septic rat skeletal muscle. Am J Physiol Heart Circ Physiol 2000, 278:H1480-1489.
21. Handa O, Stephen J, Cepinskas G. Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. Am J Physiol Heart Circ Physiol 2008, 295:H1712-1719. 10.1152/ajpheart.00476.2008, 2593506, 18723768.
22. McKinnon RL, Lidington D, Bolon M, Ouellette Y, Kidder GM, Tyml K. Reduced arteriolar conducted vasoconstriction in septic mouse cremaster muscle is mediated by nNOS-derived NO. Cardiovasc Res 2006, 69:236-244. 10.1016/j.cardiores.2005.09.003, 16226732.
23. Cauwels A. Nitric oxide in shock. Kidney Int 2007, 72:557-565. 10.1038/sj.ki.5002340, 17538569.
24. Su CF, Yang FL, Chen HI. Inhibition of inducible nitric oxide synthase attenuates acute endotoxin-induced lung injury in rats. Clin Exp Pharmacol Physiol 2007, 34:339-346. 10.1111/j.1440-1681.2007.04698.x, 17324147.
25. Su F, Huang H, Kazuki A, Occhipinti G, Donadello K, Piagnerelli M, De Backer D, Vincent JL. Effects of a selective iNOS inhibitor versus norepinephrine in the treatment of septic shock. Shock 2010,
26. Okamoto I, Abe M, Shibata K, Shimizu N, Sakata N, Katsuragi T, Tanaka K. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med 2000, 162:716-722.
27. Harada S, Imaki T, Chikada N, Naruse M, Demura H. Distinct distribution and time-course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus following lipopolysaccharide injection. Brain Res 1999, 821:322-332. 10.1016/S0006-8993(99)01124-5, 10064818.
28. Greenberg SS, Ouyang J, Zhao X, Giles TD. Human and rat neutrophils constitutively express neural nitric oxide synthase mRNA. Nitric Oxide 1998, 2:203-212. 10.1006/niox.1998.0176, 9731638.
29. Saini R, Patel S, Saluja R, Sahasrabuddhe AA, Singh MP, Habib S, Bajpai VK, Dikshit M. Nitric oxide synthase localization in the rat neutrophils: immunocytochemical, molecular, and biochemical studies. J Leukoc Biol 2006, 79:519-528. 10.1189/jlb.0605320, 16387842.
30. Mabley JG, Horvath EM, Murthy KG, Zsengeller Z, Vaslin A, Benko R, Kollai M, Szabo C. Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. J Pharmacol Exp Ther 2005, 315:812-820. 10.1124/jpet.105.090480, 16079296.
31. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab 2005, 25:502-512. 10.1038/sj.jcbfm.9600059, 15689952.
32. Szabo C, Pacher P, Swanson RA. Novel modulators of poly(ADP-ribose) polymerase. Trends Pharmacol Sci 2006, 27:626-630. 10.1016/j.tips.2006.10.003, 2228253, 17055069.
33. Shimoda K, Murakami K, Enkhbaatar P, Traber LD, Cox RA, Hawkins HK, Schmalstieg FC, Komjati K, Mabley JG, Szabo C, Salzman AL, Traber DL. Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol 2003, 285:L240-249.